We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. International Trade Commission (ITC) has said it will investigate whether Chinese company Wuhan Healthgen Biotechnology is infringing two patents owned by Kansas-based Ventria Bioscience. Read More
FDA investigators observed multiple deficiencies during an October 2020 inspection of B. Braun Medical’s sterile IV fluids facility in Daytona Beach, Florida. Read More
The Biden administration has delayed an HHS rule that would have stopped community health centers from getting federal funds unless they charged low-income patients reduced out-of-pocket prices for insulin and injectable epinephrine. Read More
Lawmakers who want to tackle sky-high drug prices are going to have lots of new ammunition, thanks to the new hospital drug pricing transparency rule from the Centers for Medicare and Medicaid Services (CMS) and the analyses that are now starting to appear because of it. Read More
Regeneron’s monoclonal antibody cocktail reduced medical visits for COVID-19 patients who had not been hospitalized by almost 50 percent, according to interim clinical trial results reported by researchers at the company. Read More
Cabenuva, the first long-acting injectable drug for HIV, has received FDA approval, providing the first-ever FDA-approved alternative to oral meds taken every day by those living with HIV. Read More
Pfizer and BioNTech have struck a supply deal with the World Health Organization (WHO)-backed COVAX program, pledging to ship up to 40 million doses of their COVID-19 vaccine this year for an undisclosed price. Read More
Eli Lilly has agreed to pay Dutch drugmaker Merus up to $1.6 billion to develop novel T-cell re-directing bispecific antibodies for treating various cancers. Read More